Do analysts recommend AHCO or YI?

AdaptHealth currently has a consensus price target of $10.29, suggesting a potential upside of 69.73%. Given AdaptHealth's stronger consensus rating and higher probable upside, analysts clearly believe AdaptHealth is more favorable than 111. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AdaptHealth 1 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.67 111 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is AHCO or YI more profitable?

111 has a net margin of -0.76% compared to AdaptHealth's net margin of -7.07%. AdaptHealth's return on equity of 3.36% beat 111's return on equity. Company Net Margins Return on Equity Return on Assets AdaptHealth -7.07% 3.36% 1.16% 111 -0.76% N/A -3.80%

Does the media favor AHCO or YI?

In the previous week, AdaptHealth had 3 more articles in the media than 111. MarketBeat recorded 6 mentions for AdaptHealth and 3 mentions for 111. 111's average media sentiment score of 0.63 beat AdaptHealth's score of 0.42 indicating that 111 is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AdaptHealth 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral 111 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer AHCO or COSM?

AdaptHealth currently has a consensus target price of $10.29, suggesting a potential upside of 69.73%. Given AdaptHealth's stronger consensus rating and higher possible upside, analysts clearly believe AdaptHealth is more favorable than Cosmos Health. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AdaptHealth 1 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.67 Cosmos Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media favor AHCO or COSM?

In the previous week, AdaptHealth had 1 more articles in the media than Cosmos Health. MarketBeat recorded 6 mentions for AdaptHealth and 5 mentions for Cosmos Health. Cosmos Health's average media sentiment score of 0.57 beat AdaptHealth's score of 0.42 indicating that Cosmos Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AdaptHealth 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Cosmos Health 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend RDGT or AHCO?

AdaptHealth has a consensus target price of $10.29, indicating a potential upside of 69.73%. Given AdaptHealth's stronger consensus rating and higher possible upside, analysts clearly believe AdaptHealth is more favorable than Ridgetech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ridgetech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 AdaptHealth 1 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.67

Which has preferable valuation & earnings, RDGT or AHCO?

Ridgetech has higher earnings, but lower revenue than AdaptHealth. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ridgetech $132.16M 0.02 -$1.25M N/A N/A AdaptHealth $3.24B 0.25 -$70.79M -$1.71 N/A

Do analysts rate MEDS or AHCO?

AdaptHealth has a consensus price target of $10.29, indicating a potential upside of 69.73%. Given AdaptHealth's stronger consensus rating and higher probable upside, analysts clearly believe AdaptHealth is more favorable than Wellgistics Health. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Wellgistics Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 AdaptHealth 1 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.67

Does the media prefer MEDS or AHCO?

In the previous week, AdaptHealth had 2 more articles in the media than Wellgistics Health. MarketBeat recorded 6 mentions for AdaptHealth and 4 mentions for Wellgistics Health. AdaptHealth's average media sentiment score of 0.42 beat Wellgistics Health's score of 0.37 indicating that AdaptHealth is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Wellgistics Health 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral AdaptHealth 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate AHCO or HKPD?

AdaptHealth presently has a consensus target price of $10.29, suggesting a potential upside of 69.73%. Given AdaptHealth's stronger consensus rating and higher possible upside, research analysts clearly believe AdaptHealth is more favorable than Hong Kong Pharma Digital Technology. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AdaptHealth 1 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.67 Hong Kong Pharma Digital Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings and valuation, AHCO or HKPD?

Hong Kong Pharma Digital Technology has lower revenue, but higher earnings than AdaptHealth. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio AdaptHealth $3.24B 0.25 -$70.79M -$1.71 N/A Hong Kong Pharma Digital Technology $13.43M 0.10 -$1.14M N/A N/A

AdaptHealth (AHCO) Competitors

$6.06 +0.21 (+3.59%)

Closing price 09/11/2026 04:00 PM Eastern

Extended Trading

$5.98 -0.09 (-1.40%)

As of 09/11/2026 07:30 PM Eastern

Compare

AHCO vs. YI, COSM, RDGT, MEDS, and HKPD

Should you buy AdaptHealth stock or one of its competitors? AdaptHealth's main competitors and comparable companies include 111 (YI), Cosmos Health (COSM), Ridgetech (RDGT), Wellgistics Health (MEDS), and Hong Kong Pharma Digital Technology (HKPD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare distributors" industry.

How does AdaptHealth compare to 111?

AdaptHealth (NASDAQ:AHCO) and 111 (NASDAQ:YI) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, risk, valuation, dividends, institutional ownership, profitability, analyst recommendations and media sentiment.

111 has lower revenue, but higher earnings than AdaptHealth. AdaptHealth is trading at a lower price-to-earnings ratio than 111, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AdaptHealth	$3.24B	0.25	-$70.79M	-$1.71	N/A
111	$1.80B	0.02	-$9.65M	-$1.40	N/A

111 has a net margin of -0.76% compared to AdaptHealth's net margin of -7.07%. AdaptHealth's return on equity of 3.36% beat 111's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AdaptHealth	-7.07%	3.36%	1.16%
111	-0.76%	N/A	-3.80%

82.7% of AdaptHealth shares are held by institutional investors. Comparatively, 21.3% of 111 shares are held by institutional investors. 2.0% of AdaptHealth shares are held by company insiders. Comparatively, 43.9% of 111 shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

AdaptHealth has a beta of 1.39, meaning that its share price is 39% more volatile than the broader market. Comparatively, 111 has a beta of 0.64, meaning that its share price is 36% less volatile than the broader market.

In the previous week, AdaptHealth had 3 more articles in the media than 111. MarketBeat recorded 6 mentions for AdaptHealth and 3 mentions for 111. 111's average media sentiment score of 0.63 beat AdaptHealth's score of 0.42 indicating that 111 is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AdaptHealth	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
111	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

AdaptHealth currently has a consensus price target of $10.29, suggesting a potential upside of 69.73%. Given AdaptHealth's stronger consensus rating and higher probable upside, analysts clearly believe AdaptHealth is more favorable than 111.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AdaptHealth	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.67
111	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

AdaptHealth beats 111 on 10 of the 16 factors compared between the two stocks.

How does AdaptHealth compare to Cosmos Health?

AdaptHealth (NASDAQ:AHCO) and Cosmos Health (NASDAQ:COSM) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, dividends, earnings, analyst recommendations, institutional ownership and risk.

AdaptHealth currently has a consensus target price of $10.29, suggesting a potential upside of 69.73%. Given AdaptHealth's stronger consensus rating and higher possible upside, analysts clearly believe AdaptHealth is more favorable than Cosmos Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AdaptHealth	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.67
Cosmos Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Cosmos Health has lower revenue, but higher earnings than AdaptHealth. AdaptHealth is trading at a lower price-to-earnings ratio than Cosmos Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AdaptHealth	$3.24B	0.25	-$70.79M	-$1.71	N/A
Cosmos Health	$65.27M	0.39	-$19.15M	-$0.64	N/A

In the previous week, AdaptHealth had 1 more articles in the media than Cosmos Health. MarketBeat recorded 6 mentions for AdaptHealth and 5 mentions for Cosmos Health. Cosmos Health's average media sentiment score of 0.57 beat AdaptHealth's score of 0.42 indicating that Cosmos Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AdaptHealth	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cosmos Health	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

AdaptHealth has a beta of 1.39, indicating that its stock price is 39% more volatile than the broader market. Comparatively, Cosmos Health has a beta of 4.8, indicating that its stock price is 380% more volatile than the broader market.

82.7% of AdaptHealth shares are owned by institutional investors. Comparatively, 12.6% of Cosmos Health shares are owned by institutional investors. 2.0% of AdaptHealth shares are owned by insiders. Comparatively, 26.2% of Cosmos Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

AdaptHealth has a net margin of -7.07% compared to Cosmos Health's net margin of -33.08%. AdaptHealth's return on equity of 3.36% beat Cosmos Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AdaptHealth	-7.07%	3.36%	1.16%
Cosmos Health	-33.08%	-56.88%	-18.03%

Summary

AdaptHealth beats Cosmos Health on 9 of the 16 factors compared between the two stocks.

How does AdaptHealth compare to Ridgetech?

Ridgetech (NASDAQ:RDGT) and AdaptHealth (NASDAQ:AHCO) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, media sentiment, valuation, dividends, profitability, risk and analyst recommendations.

Ridgetech has higher earnings, but lower revenue than AdaptHealth.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ridgetech	$132.16M	0.02	-$1.25M	N/A	N/A
AdaptHealth	$3.24B	0.25	-$70.79M	-$1.71	N/A

In the previous week, AdaptHealth had 5 more articles in the media than Ridgetech. MarketBeat recorded 6 mentions for AdaptHealth and 1 mentions for Ridgetech. Ridgetech's average media sentiment score of 1.89 beat AdaptHealth's score of 0.42 indicating that Ridgetech is being referred to more favorably in the media.

Company	Overall Sentiment
Ridgetech	Very Positive
AdaptHealth	Neutral

Ridgetech has a beta of -0.08, suggesting that its stock price is 108% less volatile than the broader market. Comparatively, AdaptHealth has a beta of 1.39, suggesting that its stock price is 39% more volatile than the broader market.

AdaptHealth has a consensus target price of $10.29, indicating a potential upside of 69.73%. Given AdaptHealth's stronger consensus rating and higher possible upside, analysts clearly believe AdaptHealth is more favorable than Ridgetech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ridgetech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
AdaptHealth	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.67

Ridgetech has a net margin of 0.00% compared to AdaptHealth's net margin of -7.07%. AdaptHealth's return on equity of 3.36% beat Ridgetech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ridgetech	N/A	N/A	N/A
AdaptHealth	-7.07%	3.36%	1.16%

45.3% of Ridgetech shares are owned by institutional investors. Comparatively, 82.7% of AdaptHealth shares are owned by institutional investors. 22.6% of Ridgetech shares are owned by company insiders. Comparatively, 2.0% of AdaptHealth shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

AdaptHealth beats Ridgetech on 10 of the 14 factors compared between the two stocks.

How does AdaptHealth compare to Wellgistics Health?

Wellgistics Health (NASDAQ:MEDS) and AdaptHealth (NASDAQ:AHCO) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, media sentiment, earnings and profitability.

5.7% of Wellgistics Health shares are held by institutional investors. Comparatively, 82.7% of AdaptHealth shares are held by institutional investors. 29.1% of Wellgistics Health shares are held by company insiders. Comparatively, 2.0% of AdaptHealth shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Wellgistics Health has a beta of -1.77, meaning that its share price is 277% less volatile than the broader market. Comparatively, AdaptHealth has a beta of 1.39, meaning that its share price is 39% more volatile than the broader market.

AdaptHealth has a net margin of -7.07% compared to Wellgistics Health's net margin of -1,100.16%. AdaptHealth's return on equity of 3.36% beat Wellgistics Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Wellgistics Health	-1,100.16%	N/A	-171.81%
AdaptHealth	-7.07%	3.36%	1.16%

In the previous week, AdaptHealth had 2 more articles in the media than Wellgistics Health. MarketBeat recorded 6 mentions for AdaptHealth and 4 mentions for Wellgistics Health. AdaptHealth's average media sentiment score of 0.42 beat Wellgistics Health's score of 0.37 indicating that AdaptHealth is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Wellgistics Health	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
AdaptHealth	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

AdaptHealth has a consensus price target of $10.29, indicating a potential upside of 69.73%. Given AdaptHealth's stronger consensus rating and higher probable upside, analysts clearly believe AdaptHealth is more favorable than Wellgistics Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Wellgistics Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
AdaptHealth	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.67

AdaptHealth has higher revenue and earnings than Wellgistics Health. AdaptHealth is trading at a lower price-to-earnings ratio than Wellgistics Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Wellgistics Health	$23.34M	0.12	-$101.28M	-$46.13	N/A
AdaptHealth	$3.24B	0.25	-$70.79M	-$1.71	N/A

Summary

AdaptHealth beats Wellgistics Health on 14 of the 16 factors compared between the two stocks.

How does AdaptHealth compare to Hong Kong Pharma Digital Technology?

AdaptHealth (NASDAQ:AHCO) and Hong Kong Pharma Digital Technology (NASDAQ:HKPD) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, earnings, risk, media sentiment, analyst recommendations and institutional ownership.

Hong Kong Pharma Digital Technology has lower revenue, but higher earnings than AdaptHealth.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AdaptHealth	$3.24B	0.25	-$70.79M	-$1.71	N/A
Hong Kong Pharma Digital Technology	$13.43M	0.10	-$1.14M	N/A	N/A

In the previous week, AdaptHealth had 4 more articles in the media than Hong Kong Pharma Digital Technology. MarketBeat recorded 6 mentions for AdaptHealth and 2 mentions for Hong Kong Pharma Digital Technology. Hong Kong Pharma Digital Technology's average media sentiment score of 1.44 beat AdaptHealth's score of 0.42 indicating that Hong Kong Pharma Digital Technology is being referred to more favorably in the news media.

Company	Overall Sentiment
AdaptHealth	Neutral
Hong Kong Pharma Digital Technology	Positive

AdaptHealth presently has a consensus target price of $10.29, suggesting a potential upside of 69.73%. Given AdaptHealth's stronger consensus rating and higher possible upside, research analysts clearly believe AdaptHealth is more favorable than Hong Kong Pharma Digital Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AdaptHealth	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.67
Hong Kong Pharma Digital Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Hong Kong Pharma Digital Technology has a net margin of 0.00% compared to AdaptHealth's net margin of -7.07%. AdaptHealth's return on equity of 3.36% beat Hong Kong Pharma Digital Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AdaptHealth	-7.07%	3.36%	1.16%
Hong Kong Pharma Digital Technology	N/A	N/A	N/A

82.7% of AdaptHealth shares are held by institutional investors. 2.0% of AdaptHealth shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

AdaptHealth has a beta of 1.39, suggesting that its stock price is 39% more volatile than the broader market. Comparatively, Hong Kong Pharma Digital Technology has a beta of 2.23, suggesting that its stock price is 123% more volatile than the broader market.

Summary

AdaptHealth beats Hong Kong Pharma Digital Technology on 10 of the 14 factors compared between the two stocks.

Get AdaptHealth News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AHCO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AHCO vs. The Competition

Export

Metric	AdaptHealth	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$797.61M	$9.88B	$7.13B	$12.72B
Dividend Yield	N/A	2.61%	2.56%	11.15%
P/E Ratio	-3.54	33.53	275.24	25.29
Price / Sales	0.25	5.55	656.02	98.94
Price / Cash	1.40	125.76	77.04	51.44
Price / Book	0.54	5.29	10.33	6.20
Net Income	-$70.79M	$313.25M	$3.50B	$358.50M
7 Day Performance	-6.63%	-1.26%	-3.32%	-2.35%
1 Month Performance	5.03%	-0.98%	-0.41%	-2.77%
1 Year Performance	-34.77%	15.13%	19.21%	7.63%

AdaptHealth Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AHCO AdaptHealth	3.6169 of 5 stars	$6.06 +3.6%	$10.29 +69.7%	-36.4%	$797.61M	$3.24B	N/A	10,900	News Coverage
YI 111	0.6271 of 5 stars	$3.42 -1.2%	N/A	-38.0%	$30.06M	$1.80B	N/A	1,063	Gap Down
COSM Cosmos Health	1.3746 of 5 stars	$0.27 -2.6%	N/A	-69.8%	$26.87M	$65.27M	N/A	100	News Coverage
RDGT Ridgetech	1.0421 of 5 stars	$0.90 -1.3%	N/A	-99.6%	$3.25M	$132.16M	N/A	980	Gap Down
MEDS Wellgistics Health	0.2124 of 5 stars	$0.90 -2.3%	N/A	-98.8%	$2.86M	$23.34M	N/A	31	News Coverage Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:AHCO) was last updated on 9/12/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

AdaptHealth (AHCO) Competitors

AHCO vs. YI, COSM, RDGT, MEDS, and HKPD

How does AdaptHealth compare to 111?

Summary

How does AdaptHealth compare to Cosmos Health?

Summary

How does AdaptHealth compare to Ridgetech?

Summary

How does AdaptHealth compare to Wellgistics Health?

Summary

How does AdaptHealth compare to Hong Kong Pharma Digital Technology?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AHCO vs. The Competition

AdaptHealth Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

AdaptHealth (AHCO) Competitors

AHCO vs. YI, COSM, RDGT, MEDS, and HKPD

How does AdaptHealth compare to 111?

Which has preferable valuation and earnings, AHCO or YI?

Is AHCO or YI more profitable?

Do institutionals and insiders hold more shares of AHCO or YI?

Which has more risk & volatility, AHCO or YI?

Does the media favor AHCO or YI?

Do analysts recommend AHCO or YI?

Summary

How does AdaptHealth compare to Cosmos Health?

Do analysts prefer AHCO or COSM?

Which has preferable earnings and valuation, AHCO or COSM?

Does the media favor AHCO or COSM?

Which has more volatility and risk, AHCO or COSM?

Do institutionals & insiders have more ownership in AHCO or COSM?

Is AHCO or COSM more profitable?

Summary

How does AdaptHealth compare to Ridgetech?

Which has preferable valuation & earnings, RDGT or AHCO?

Does the media prefer RDGT or AHCO?

Which has more volatility and risk, RDGT or AHCO?

Do analysts recommend RDGT or AHCO?

Is RDGT or AHCO more profitable?

Do institutionals and insiders have more ownership in RDGT or AHCO?

Summary

How does AdaptHealth compare to Wellgistics Health?

Do insiders and institutionals have more ownership in MEDS or AHCO?

Which has more risk and volatility, MEDS or AHCO?

Is MEDS or AHCO more profitable?

Does the media prefer MEDS or AHCO?

Do analysts rate MEDS or AHCO?

Which has stronger earnings & valuation, MEDS or AHCO?

Summary

How does AdaptHealth compare to Hong Kong Pharma Digital Technology?

Which has preferable earnings and valuation, AHCO or HKPD?

Does the media favor AHCO or HKPD?

Do analysts rate AHCO or HKPD?

Is AHCO or HKPD more profitable?

Do insiders & institutionals have more ownership in AHCO or HKPD?

Which has more volatility and risk, AHCO or HKPD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AHCO vs. The Competition

AdaptHealth Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools